- You are viewing a Navigating Care library resource.
- Go to Library
Treatment of Recurrent Primary CNS Lymphoma
For information about the treatments listed below, see the Treatment Option Overview section.
Treatment of recurrent primary central nervous system (CNS) lymphoma may include the following:
- Chemotherapy.
- Targeted therapy (rituximab, nivolumab, or ibrutinib).
- Stem cell transplant.
- CAR T-cell therapy.
- Radiation therapy (if not received in earlier treatment).
- A clinical trial of targeted therapy (rituximab and ibrutinib) and chemotherapy.
This information is not intended to replace the advice of a doctor.
Navigating Care disclaims any liability for the decisions you make based on this information.
This information was sourced and adapted from Adapted from the National Cancer Institute's
Physician Data Query (PDQ®) Cancer Information Summaries on
www.cancer.gov.
This information updated
October 1, 2024.
Learn more:
Related Articles
See Expert Resources
The Navigating Care Library includes articles about cancer, chemotherapy regimens and drugs from the
the National Cancer Institute and other experts.
